Distinguished in Obesity

Stephanie Kullmann

Tuebingen, BW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Obesity
Tuebingen, BW, DE 
OverviewLocationsClinical Research

Overview

Stephanie Kullmann practices in Tuebingen, Germany. Ms. Kullmann is rated as a Distinguished expert by MediFind in the treatment of Obesity. Her top areas of expertise are Obesity, Type 2 Diabetes (T2D), Anorexia, and Congenital Hyperinsulinism.

Her clinical research consists of co-authoring 85 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 34 articles and participated in 3 clinical trials in the study of Obesity.

Gender
Female

Locations

Tuebingen, BW, Germany
Other Locations
Munich, BY 85764, Germany
Neuherberg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Dopamine Action on Metabolism Depending on Genetic Heterogeneity - a Randomized, Placebo-controlled Double Blind Study
Dopamine Action on Metabolism Depending on Genetic Heterogeneity - a Randomized, Placebo-controlled Double Blind Study
Enrollment Status: Recruiting
Publish Date: February 02, 2024
Intervention Type: Drug, Other
Study Drug: Bromocriptine
Study Phase: Phase 2
Metabolic Characterization of Subjects With Adipositas Before and After Bariatric Surgery
Metabolic Characterization of Subjects With Adipositas Before and After Bariatric Surgery
Enrollment Status: Terminated
Publish Date: January 05, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Einfluss Von Hochkalorischer Nahrungsaufnahme Auf Die Insulinsensitivität Des Menschlichen Zentralnervensystems
Einfluss Von Hochkalorischer Nahrungsaufnahme Auf Die Insulinsensitivität Des Menschlichen Zentralnervensystems
Enrollment Status: Completed
Publish Date: May 20, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trial

85 Total Publications

Circulating epigenetic signatures classifying brain insulin resistance in humans.
Circulating epigenetic signatures classifying brain insulin resistance in humans.
Journal: Science translational medicine
Published: August 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kullmann's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile